Cardiovascular effects of hexoprenaline sulphate and salbutamol in man.
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D000328:Adult; D000605:Amino Alcohols / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*; D002082:Butylamines / Q000494:pharmacology; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002396:Catechols / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D010100:Oxygen / Q000097:blood; D010627:Phenethylamines / Q000494:pharmacology*; D012119:Respiration; D014655:Vascular Resistance / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002082:Butylamines; D002396:Catechols; D004983:Ethanolamines; D010627:Phenethylamines; D002245:Carbon Dioxide; D010100:Oxygen